NCT03540017 - HIPEC After Initial CRS in Patients Who Have Received NACT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

July 5, 2024

Study Completion Date

July 5, 2025

Conditions

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma

Interventions

DRUG

Cisplatin

Heated Intraperitoneal Chemotherapy will be administered after the completion of interval cytoreductive surgery after three cycles of neoadjuvant chemotherapy.

Trial Locations (1)

11040

RECRUITING

Long Island Jewish Medical Center, New Hyde Park